Published in J Pharmacol Exp Ther on October 01, 1989
Predominant role of the dopamine D3 receptor subtype for mediating the quinpirole-induced inhibition of the vasopressor sympathetic outflow in pithed rats. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.76
Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev (1972) 5.07
Comparison of the effects of dopamine, isoproterenol, norepinephrine and bradykinin on canine renal and femoral blood flow. J Pharmacol Exp Ther (1966) 2.52
Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: evidence for a specific dopamine receptor. J Pharmacol Exp Ther (1969) 2.11
Dopamine--clinical uses of an endogenous catecholamine. N Engl J Med (1974) 1.89
Dopamine in the treatment of hypotension and shock. N Engl J Med (1966) 1.77
The potential role of dopamine in the treatment of shock. Prog Cardiovasc Dis (1969) 1.70
Effects of hypoxia on interleukin-2 mRNA expression by T lymphocytes. Crit Care Med (1994) 1.53
STUDIES ON DIGITALIS. IV. OBSERVATIONS IN MAN ON THE EFFECTS OF DIGITALIS PREPARATIONS ON THE CONTRACTILITY OF THE NON-FAILING HEART AND ON TOTAL VASCULAR RESISTANCE. J Clin Invest (1961) 1.45
A comparison of the vascular dopamine receptor with other dopamine receptors. Annu Rev Pharmacol Toxicol (1978) 1.41
Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine. Prog Cardiovasc Dis (1977) 1.32
The use of quaternary narcotic antagonists in opiate research. Neuropharmacology (1985) 1.27
Effects of dopamine on isolated canine coronary arteries. Cardiovasc Res (1975) 1.23
Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J Pharmacol Exp Ther (1984) 1.17
A hemodynamic comparison of dopamine and isoproterenol in patients in shock. Circulation (1969) 1.14
Effects of dopamine on renal function and hemodynamics in the dog. J Pharmacol Exp Ther (1967) 1.12
Use of sympathomimetic amines in heart failure. Am J Cardiol (1968) 1.11
Sodium nitroprusside treatment of ergotamine-induced peripheral ischemia. JAMA (1974) 1.11
An investigation of the structural requirements for dopamine-like renal vasodilation: phenylethylamines and apomorphine. J Pharmacol Exp Ther (1968) 1.11
Attenuation of dopamine-induced renal vasodilation in the dog by phenothiazines. Eur J Pharmacol (1971) 1.09
Selective DA2 versus DA1 antagonist activity of domperidone in the periphery. Eur J Pharmacol (1983) 1.07
Dopamine receptors: applications in clinical cardiology. Circulation (1985) 1.03
Excitatory action of sympathomimetic amines on 5-hydroxytryptamine receptors of gut. Br J Pharmacol (1969) 1.01
Recent advances in the pharmacology of catecholamines. Intensive Care Med (1977) 1.00
Peripheral pre- and post-synaptic dopamine receptors: are they different from dopamine receptors in the central nervous system? Commun Psychopharmacol (1979) 1.00
Dopamine-like renal and mesenteric vasodilation caused by apomorphine 6-propylnorapomorphine and 2-amino-6, 7-dihydroxy-1,2,3,4-tetrahydronaphthalene. Nature (1976) 1.00
Histofluorescence techniques provide evidence for dopamine-containing neuronal elements in canine kidney. Science (1979) 0.99
Augmentation of sodium and potassium excretion, glomerular filtration rate and renal plasma flow by levodopa. N Engl J Med (1971) 0.97
Effects of maintenance digoxin therapy on systolic time intervals and serum digoxin concentrations. Circulation (1974) 0.94
Attenuation of postganglionic sympathetic nerve activity by L-dopa. Circ Res (1970) 0.93
Adrenoceptive receptors in the duodenum, aorta and atria of the rabbit. J Pharm Pharmacol (1967) 0.92
Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists. Eur J Pharmacol (1982) 0.92
Regional variation in the alpha-adrenergic receptors in the canine resistance vessels. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.92
Characteristics of the vascular dopamine receptor: comparison with other receptors. Fed Proc (1978) 0.91
2,3-Dihydroxy-9-amino-9,10-dihydrophenanthrene, a rigid congener of dopamine and isoapomorphine. J Med Chem (1978) 0.91
The treatment of cardiogenic shock. VI. The search for an ideal drug. Am Heart J (1968) 0.91
Blockade of renal effects of dopamine in the dog by the DA1 antagonist SCH 23390. Am J Physiol (1985) 0.90
Characterization by cyproheptadine of the dopamine-induced contraction in canine isolated arteries. J Pharmacol Exp Ther (1975) 0.90
Absorption and excretion of 2,4-dichlorophenoxyacetic acid in man. Xenobiotica (1974) 0.90
Dopamine receptors and hypertension. Physiologic and pharmacologic implications. Am J Med (1984) 0.89
A comparative study of dopamine and noradrenaline on the rabbit aorta. Can J Physiol Pharmacol (1969) 0.88
Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients. Br J Clin Pharmacol (1988) 0.88
Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam. Circulation (1987) 0.88
Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels. Circulation (1986) 0.87
Dopamine induced relaxation of isolated canine renal, mesenteric, and femoral arteries contracted with prostaglandin F2-alpha. Circ Res (1975) 0.87
Propylbutyldopamine: hemodynamic effects in conscious dogs, normal human volunteers and patients with heart failure. Circulation (1983) 0.87
Separation of peripheral dopamine receptors by a selective DA1 antagonist, SCH 23390. Hypertension (1984) 0.86
Cardiovascular effects of levodopa. JAMA (1971) 0.86
Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog. J Pharmacol Exp Ther (1987) 0.86
Effects of levodopa on systolic preejection period, blood pressure, and heart rate during acute and chronic treatment of Parkinson's disease. Circulation (1972) 0.86
The dopamine vascular receptor. Biochem Pharmacol (1975) 0.86
Cardiovascular effects of (--)-cathinone in the anaesthetized dog: comparison with (+)-amphetamine. J Pharm Pharmacol (1982) 0.86
Insidious and prolonged antagonism of guanethidine by amitriptyline. JAMA (1970) 0.85
Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism. Eur J Pharmacol (1986) 0.85
Alpha-adrenergic blocking action of propranolol. J Pharm Pharmacol (1967) 0.85
Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors. J Pharmacol Exp Ther (1980) 0.85
Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans. Xenobiotica (1989) 0.85
Dopamine agonist properties of N-alkyl-4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines. J Med Chem (1981) 0.84
Panel 1: phase I investigations. Clin Pharmacol Ther (1975) 0.84
Cardiovascular and renal hemodynamic effects of intravenous infusions of the selective DA1 agonist, fenoldopam, used alone or in combination with dopamine and dobutamine. Circulation (1988) 0.83
Dopamine in the treatment of heart failure. Eur Heart J (1982) 0.83
Alpha-adrenoceptor blocking activity of fenoldopam (SK&F 82526), a selective DA1 agonist. J Pharm Pharmacol (1986) 0.83
Comparative systemic and regional hemodynamic effects of dopamine and dobutamine. Am Heart J (1975) 0.82
Dopamine-induced relaxation of isolated arterial strips. J Pharm Pharmacol (1973) 0.82
Beneficial hemodynamic effects of oral levodopa in heart failure. Relation to the generation of dopamine. N Engl J Med (1984) 0.82
Comparison of putative dopamine receptors in blood vessels and the central nervous system. Adv Neurol (1975) 0.82
Combined use of dopamine and prostaglandin A1 in patients with acute renal failure and hepatorenal syndrome. Prostaglandins (1978) 0.82
Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs. J Clin Pharmacol (1993) 0.81
Receptors for sympathomimetic amines in the rabbit aorta: differentiation by specific antagonists. Br J Pharmacol Chemother (1968) 0.81
Extraadrenal pheochromocytoma: detection during pregnancy using MR imaging. Radiology (1986) 0.81
Sulpiride: a weak antagonist of norepinephrine and 5-hydroxytryptamine. Eur J Pharmacol (1979) 0.81
Increased clearances of phenobarbital and salicylate produced by dopamine in the dog. Am J Med Sci (1969) 0.81
Guancydine: a new antihypertensive agent. Use with quinethazone and guanethidine or propranolol. Ann Intern Med (1972) 0.81
Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats. Hypertension (1986) 0.81
Antagonism of prostanoid-induced vascular contraction by 13-azaprostanoic acid (13-APA). J Cardiovasc Pharmacol (1984) 0.81
Effects of selective dopamine receptor agonists in rats trained to discriminate apomorphine from saline. Pharmacol Biochem Behav (1985) 0.81
Reversal of morphine-induced catalepsy in the rat by narcotic antagonists and their quaternary derivatives. Neuropharmacology (1983) 0.80
Potential use of DA1 and DA2 receptor agonists in the treatment of hypertension. Clin Exp Hypertens A (1987) 0.80
N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist. J Pharmacol Exp Ther (1978) 0.80
Comparison of the effects of dopamine and beta-adrenergic agonists on adenylate cyclase of renal glomeruli and striatum. Mol Pharmacol (1981) 0.80
Comparison of the cardiovascular actions of dopamine and epinine in the dog. J Pharmacol Exp Ther (1985) 0.80
Current therapy of shock. Adv Intern Med (1971) 0.79
Blockade of the discriminative stimulus effects of cocaine in rhesus monkeys with the D1 dopamine antagonist SCH 23390. Psychopharmacology (Berl) (1988) 0.79
Preservation of renal blood flow during hypotension induced with fenoldopam in dogs. Can J Anaesth (1990) 0.79
Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine. Cancer Chemother Pharmacol (1998) 0.79
Hemodynamic consequences of administration of phentolamine or nitroprusside with dopamine in the dog. J Cardiovasc Pharmacol (1980) 0.79
Effects of fenoldopam on renal blood flow and systemic hemodynamics during isoflurane anesthesia. J Cardiothorac Vasc Anesth (1991) 0.79
Dopamine: receptors and clinical applications. Clin Physiol Biochem (1985) 0.79
Contractile actions of racemic and d-propranolol on isolated canine mesenteric and coronary arteries. J Pharmacol Exp Ther (1982) 0.78